These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35948575)

  • 81. Clinical utility of MR/ultrasound fusion-guided biopsy in patients with lower suspicion lesions on active surveillance for low-risk prostate cancer.
    Lokeshwar SD; Nguyen J; Rahman SN; Khajir G; Ho R; Ghabili K; Leapman MS; Weinreb JC; Sprenkle PC
    Urol Oncol; 2022 Sep; 40(9):407.e21-407.e27. PubMed ID: 35811206
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
    Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
    Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients.
    El-Helaly HA; Mahmoud AA; Magdy AM; Hasehem A; Ibrahim HM; Mohamed KM; Ismail MH
    J Egypt Natl Canc Inst; 2023 Mar; 35(1):5. PubMed ID: 36872409
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Feasibility and preliminary clinical tolerability of low-field MRI-guided prostate biopsy.
    Sze C; Singh Z; Punyala A; Satya P; Sadinski M; Narayan R; Nacev A; Kumar D; Adams J; Nicholas K; Margolis D; Chughtai B
    Prostate; 2023 May; 83(7):656-662. PubMed ID: 36808735
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of Targeted Biopsy and Combined Biopsy to Avoid Unnecessary Systematic Biopsy in Patients with PI-RADS 5 Lesions.
    Yuan C; Li D; Wu J; Shen Q; Wang X; Xiao J; He Z; Zhou L; Li X; Liu Y; Zhao Z
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137384
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion-targeted biopsy in patients with a solitary PI-RADS v2-scored lesion.
    Syed JS; Nguyen KA; Nawaf CB; Bhagat AM; Huber S; Levi A; Humphrey P; Weinreb JC; Schulam PG; Sprenkle PC
    Urol Oncol; 2017 Sep; 35(9):542.e19-542.e24. PubMed ID: 28501565
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Reconciling discordance between PI-RADS 4 lesions and targeted biopsy: Early experience of a multidisciplinary quality improvement protocol with PI-RADS 4 subcategorization.
    Deivasigamani S; Kotamarti S; Adams ES; Séguier D; Zhang D; Michael Z; Polascik TJ; Gupta RT
    Eur J Radiol; 2023 Aug; 165():110929. PubMed ID: 37352682
    [TBL] [Abstract][Full Text] [Related]  

  • 88. MRI-based analysis of different clinically significant prostate cancer detection rate of prostate imaging reporting and data system score 4 in the peripheral zone.
    Sun Z; Wang H; Fu W; Zhu S; Song G
    Abdom Radiol (NY); 2023 Jan; 48(1):390-398. PubMed ID: 36305943
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prostate cancer: diagnostic yield of modified transrectal ultrasound-guided twelve-core combined biopsy (targeted plus systematic biopsies) using prebiopsy magnetic resonance imaging.
    Song C; Park SY
    Abdom Radiol (NY); 2021 Oct; 46(10):4974-4983. PubMed ID: 34181040
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A Prospective Comparison of Transrectal Standard, Cognitive, Transperineal Fusion, and Mapping Prostate Biopsy for Cancer Detection.
    Petov V; Bazarkin A; Morozov A; Taratkin M; Ganzha T; Danilov S; Chernov Y; Chinenov D; Rzayev R; Suvorov A; Amosov A; Fajkovic H; Enikeev D; Krupinov G
    J Endourol; 2023 Aug; 37(8):940-947. PubMed ID: 37294206
    [No Abstract]   [Full Text] [Related]  

  • 91. Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily Practice.
    Cecchini S; Castellani D; Fabbietti P; Mazzucchelli R; Montironi R; Cecarini M; Carnevali F; Pierangeli T; Dellabella M; Ravasi E
    Clin Genitourin Cancer; 2020 Oct; 18(5):e501-e509. PubMed ID: 32147365
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.
    Klotz L; Chin J; Black PC; Finelli A; Anidjar M; Bladou F; Mercado A; Levental M; Ghai S; Chang SD; Milot L; Patel C; Kassam Z; Moore C; Kasivisvanathan V; Loblaw A; Kebabdjian M; Earle CC; Pond GR; Haider MA
    JAMA Oncol; 2021 Apr; 7(4):534-542. PubMed ID: 33538782
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Confirmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassification rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsy.
    Pepe P; Pepe L; Pennisi M; Fraggetta F
    Arch Ital Urol Androl; 2022 Sep; 94(3):270-273. PubMed ID: 36165468
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial.
    Saner YM; Wiesenfarth M; Weru V; Ladyzhensky B; Tschirdewahn S; Püllen L; Bonekamp D; Reis H; Krafft U; Heß J; Kesch C; Darr C; Forsting M; Wetter A; Umutlu L; Haubold J; Hadaschik B; Radtke JP
    Eur Urol Oncol; 2023 Feb; 6(1):49-55. PubMed ID: 36175281
    [TBL] [Abstract][Full Text] [Related]  

  • 95. MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
    Schoots IG
    Transl Androl Urol; 2018 Feb; 7(1):70-82. PubMed ID: 29594022
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Diagnostic performance of regional systematic biopsy for prostate cancer stratified by PI-RADS and histologic zones.
    Sun Z; Liu Y; Yu W; Wang H; Shen Q; Zhang C
    Insights Imaging; 2024 May; 15(1):118. PubMed ID: 38755502
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The role of PSA kinetics in men with a negative MRI-targeted prostate biopsy.
    Bigarella MP; Das A; Garcia D; Brackman K; Allen G; Jarrard D
    Am J Clin Exp Urol; 2024; 12(3):141-148. PubMed ID: 39021398
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Robotic-assisted laparoscopic radical prostatectomy for treatment of a newly identified lesion revealed no viable cells in the previously treated area with microwave focal therapy.
    Tsukuda F; Shimizu T; Hagiwara K; Kawano Y; Sakamoto N; Itagaki S; Horiguchi Y; Koga S; Ukimura O
    IJU Case Rep; 2024 Jul; 7(4):313-315. PubMed ID: 38966774
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Primary follicular lymphoma of the prostate co-existing with grade group 5 prostatic adenocarcinoma and presenting as a PI-RADS lesion 4 on mpMRI.
    Bal S; Odujoko O; Fiedler J; Sieber SC; Beck E; Gupta G
    Urol Case Rep; 2024 May; 54():102708. PubMed ID: 38550656
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Expect the unexpected: investigating discordant prostate MRI and biopsy results.
    Stanzione A; Lee KL; Sanmugalingam N; Rajendran I; Sushentsev N; Caglič I; Barrett T
    Eur Radiol; 2024 Jul; 34(7):4810-4820. PubMed ID: 38503918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.